YCBD Earnings

YCBD reported its earnings on 2026-02-17, showcasing a revenue of 5.02M against an estimate of 4.86M, resulting in a 3.27% surprise. The EPS was -0.04, surpassing the expected -0.06 by 33.33%. The stock experienced a -6.83% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following YCBD's earnings announcement on 2026-02-17, the stock price moved by -6.83% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, YCBD's stock price tends to shift by an average of 11.01% in the 10 days leading up to earnings and -5.87% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate YCBD's annual revenue to reach 4.89M, while the EPS is projected at -0.06. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between YCBD's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, YCBD's stock price typically moves by 11.01% in the 10 days before its earnings and -5.87% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.06 and revenue of 4.89M.

The earnings call reflects mixed signals: a 12% revenue increase and improved liquidity are positive, but declining margins, a net loss, and integration risks weigh negatively. The Q&A reveals uncertainty, particularly around the Herbal Oasis product line, and management's vague responses may concern investors. The lack of market cap data limits assessment of stock reaction magnitude, but overall, the sentiment aligns with a neutral prediction given the balanced positives and negatives.